Aseptic meningitis and muromonab-CD3 therapy.
Drees
C
C
Drug Information Service, University of Kansas Medical Center, Kansas City 66103.
Haley
C J
CJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy; D008582:Meningitis, Aseptic / Q000139:chemically induced*; D016853:Muromonab-CD3
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3